Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Boers

Showing results (221-230 of 277) with videos related to

Pageof 28
Sort By:
Scandinavian Journal of Rheumatology|June 19, 2019
Suboptimal cardiovascular risk management in rheumatoid arthritis patients despite an explicit cardiovascular risk screening programmeM Heslinga, Iam Van Den Oever, D L Jonker, et al.
Food Additives & Contaminants. Part A, Chemistry, Analysis, Control, Exposure & Risk Assessment|May 26, 2012
Occurrence of Fusarium Head Blight species and Fusarium mycotoxins in winter wheat in the Netherlands in 2009H J van der Fels-Klerx, T C de Rijk, C J H Booij, et al.
Annals of the Rheumatic Diseases|August 19, 2003
Influence of glucocorticoids and disease activity on total and high density lipoprotein cholesterol in patients with rheumatoid arthritisM Boers, M T Nurmohamed, C J A Doelman, et al.
Seminars in Arthritis and Rheumatism|November 26, 2022
In RA patients without prevalent CVD, incident CVD is mainly associated with traditional risk factors: A 20-year follow-up in the CARRÉ cohort studyR Raadsen, R Agca, M Boers, et al.
Scandinavian Journal of Rheumatology|May 28, 2019
Remarkable international variability in reasons for ineligibility and non-participation in the GLORIA trialL Hartman, R Bos, F Buttgereit, et al.
Annals of the Rheumatic Diseases|August 19, 2005
Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial dataJ A P Da Silva, J W G Jacobs, J R Kirwan, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 19, 2021
Long-term effects on bone mineral density after four years of treatment with two intensive combination strategies, including initially high-dose prednisolone, in early rheumatoid arthritis patients: the COBRA-light trialM J J Lucassen, M M Ter Wee, D den Uyl, et al.
AJNR. American Journal of Neuroradiology|April 2, 2016
Assessment of Collateral Status by Dynamic CT Angiography in Acute MCA Stroke: Timing of Acquisition and Relationship with Final Infarct VolumeI R van den Wijngaard, G Holswilder, M J H Wermer, et al.
Annals of the Rheumatic Diseases|April 14, 2009
Arthritis development in patients with arthralgia is strongly associated with anti-citrullinated protein antibody status: a prospective cohort studyW H Bos, G J Wolbink, M Boers, et al.
The Journal of Rheumatology|March 25, 1999
Imaging in rheumatoid arthritis: results of group discussionsE T Molenaar, M Boers, D M van der Heijde, et al.
Pageof 28

Showing results (221-230 of 277) with videos related to

Sort By:
Pageof 28
Scandinavian Journal of Rheumatology|June 19, 2019
Suboptimal cardiovascular risk management in rheumatoid arthritis patients despite an explicit cardiovascular risk screening programmeM Heslinga, Iam Van Den Oever, D L Jonker, et al.
Food Additives & Contaminants. Part A, Chemistry, Analysis, Control, Exposure & Risk Assessment|May 26, 2012
Occurrence of Fusarium Head Blight species and Fusarium mycotoxins in winter wheat in the Netherlands in 2009H J van der Fels-Klerx, T C de Rijk, C J H Booij, et al.
Annals of the Rheumatic Diseases|August 19, 2003
Influence of glucocorticoids and disease activity on total and high density lipoprotein cholesterol in patients with rheumatoid arthritisM Boers, M T Nurmohamed, C J A Doelman, et al.
Seminars in Arthritis and Rheumatism|November 26, 2022
In RA patients without prevalent CVD, incident CVD is mainly associated with traditional risk factors: A 20-year follow-up in the CARRÉ cohort studyR Raadsen, R Agca, M Boers, et al.
Scandinavian Journal of Rheumatology|May 28, 2019
Remarkable international variability in reasons for ineligibility and non-participation in the GLORIA trialL Hartman, R Bos, F Buttgereit, et al.
Annals of the Rheumatic Diseases|August 19, 2005
Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial dataJ A P Da Silva, J W G Jacobs, J R Kirwan, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 19, 2021
Long-term effects on bone mineral density after four years of treatment with two intensive combination strategies, including initially high-dose prednisolone, in early rheumatoid arthritis patients: the COBRA-light trialM J J Lucassen, M M Ter Wee, D den Uyl, et al.
AJNR. American Journal of Neuroradiology|April 2, 2016
Assessment of Collateral Status by Dynamic CT Angiography in Acute MCA Stroke: Timing of Acquisition and Relationship with Final Infarct VolumeI R van den Wijngaard, G Holswilder, M J H Wermer, et al.
Annals of the Rheumatic Diseases|April 14, 2009
Arthritis development in patients with arthralgia is strongly associated with anti-citrullinated protein antibody status: a prospective cohort studyW H Bos, G J Wolbink, M Boers, et al.
The Journal of Rheumatology|March 25, 1999
Imaging in rheumatoid arthritis: results of group discussionsE T Molenaar, M Boers, D M van der Heijde, et al.
Pageof 28